Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 1Radiodermatitis 1Polycystic Ovary Syndrome 1Peripheral Nervous System Diseases 1Disease Progression 1Cisplatin Nephrotoxicity 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Breast Cancer Female 1

Interventions

pembrolizumab 2enfortumab vedotin 2Tablets 2Exercise 2Acupuncture Therapy 2nicotinamide-beta-riboside 1Vitamin B Complex 1Thioctic Acid 1Tadalafil 1Single Person 1Rosuvastatin Calcium 1Omeprazole 1Memantine 1Massage 1Lenalidomide 1Gloves, Surgical 1Fish Oils 1Fenofibrate 1Exercise Therapy 1Dexamethasone 1Cryotherapy 1Corn Oil 1Control Groups 1Bortezomib 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Peripheral Nervous System Diseases × Thioctic Acid × 1 year × Clear all
NCT07501663 2026-04-14

Optimizing Integrative Oncology Approaches to Address Chemotherapy-induced Peripheral Neuropathy in Gastrointestinal (GI) Cancer Patients: A SMART Pilot Study

Thomas Jefferson University

Phase NA Recruiting
60 enrolled

Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡